Plasma phospholipids exchange on to the erythrocyte membrane Lipids: With different age groups and anti diabetic therapy.

Basavaraj Aski, N S Biradar SS Walvekar  Kashinath RT

dc.contributor.author	Basavaraj Aski, N S Biradar SS Walvekar Kashinath RT
dc.date.accessioned	2020-05-19T11:06:41Z
dc.date.available	2020-05-19T11:06:41Z
dc.date.issued	2014-07
dc.identifier.uri	http://hdl.handle.net/123456789/2364
dc.description.abstract	Dyslipideamia is a major cause, observed in type 2 diabetic subjects with micro vascular complications and membrane functional alteration is very common. The relative amount of phospholipids and cholesterol is responsible entity for normal function and membrane fluidity and rigidity. Many research studies reported on plasma lipid anomaly even on anti diabetic agents and also our earlier laboratory study supports, influence of anti diabetic therapy on plasma lipids and its relation to lipid alteration in erythrocyte membrane of diabetic subjects.	en_US
dc.language.iso	en	en_US
dc.publisher	B.L.D.E.(Deemed to be University)	en_US
dc.subject	Anti diabetic Therapy, phospholipids (PL), Total Cholesterol (TC) ,RBC Membrane	en_US
dc.title	Plasma phospholipids exchange on to the erythrocyte membrane Lipids: With different age groups and anti diabetic therapy.	en_US
dc.type	Article	en_US